Want to see HK:1066 full AI Analyst Report?
Total Valuation
Shandong Weigao Group Medical Polymer Co has a market cap or net worth of HK$14.97B. The enterprise value is HK$11.73B.
Market CapHK$14.97B
Enterprise ValueHK$11.73B
Share Statistics
Shandong Weigao Group Medical Polymer Co has 4,522,332,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,522,332,500
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Shandong Weigao Group Medical Polymer Co’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.60%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.60%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.01M
Profits Per Employee152.63K
Employee Count13,310
Asset Turnover0.37
Inventory Turnover2.81
Valuation Ratios
The current PE Ratio of Shandong Weigao Group Medical Polymer Co is 9.4. Shandong Weigao Group Medical Polymer Co’s PEG ratio is -0.54.
PE Ratio9.4
PS Ratio1.53
PB Ratio0.85
Price to FCF11.91
Price to Operating Cash Flow4.54
PEG Ratio-0.54
Income Statement
In the last 12 months, Shandong Weigao Group Medical Polymer Co had revenue of 13.39B and earned 1.61B in profits. Earnings per share was 0.35.
Revenue13.39B
Gross Profit6.33B
Operating Income1.70B
Pretax Income2.03B
Net Income1.61B
EBITDA2.83B
Earnings Per Share (EPS)0.35
Cash Flow
In the last 12 months, operating cash flow was 2.80B and capital expenditures -1.73B, giving a free cash flow of 1.08B billion.
Operating Cash Flow2.80B
Free Cash Flow1.08B
Free Cash Flow per Share0.24
Dividends & Yields
Shandong Weigao Group Medical Polymer Co pays an annual dividend of HK$0.1, resulting in a dividend yield of 5.09%
Dividend Per ShareHK$0.1
Dividend Yield5.09%
Payout Ratio49.43%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change-37.85%
50-Day Moving Average3.19
200-Day Moving Average3.70
Relative Strength Index (RSI)60.88
Average Volume (3m)7.18M
Important Dates
Shandong Weigao Group Medical Polymer Co upcoming earnings date is Mar 30, 2027, TBA (Confirmed).
Last Earnings DateAug 25, 2026
Next Earnings DateMar 30, 2027
Ex-Dividend Date―
Financial Position
Shandong Weigao Group Medical Polymer Co as a current ratio of 3.78, with Debt / Equity ratio of 20.32%
Current Ratio3.78
Quick Ratio3.32
Debt to Market Cap0.23
Net Debt to EBITDA-1.06
Interest Coverage Ratio6.82
Taxes
In the past 12 months, Shandong Weigao Group Medical Polymer Co has paid 320.79M in taxes.
Income Tax320.79M
Effective Tax Rate0.16
Enterprise Valuation
Shandong Weigao Group Medical Polymer Co EV to EBITDA ratio is 6.16, with an EV/FCF ratio of 10.17.
EV to Sales1.30
EV to EBITDA6.16
EV to Free Cash Flow10.17
EV to Operating Cash Flow6.85
Balance Sheet
Shandong Weigao Group Medical Polymer Co has HK$8.92B in cash and marketable securities with HK$4.96B in debt, giving a net cash position of HK$3.96B billion.
Cash & Marketable SecuritiesHK$8.92B
Total DebtHK$4.96B
Net CashHK$3.96B
Net Cash Per ShareHK$0.88
Tangible Book Value Per ShareHK$4.65
Margins
Gross margin is 45.56%, with operating margin of 12.69%, and net profit margin of 12.04%.
Gross Margin45.56%
Operating Margin12.69%
Pretax Margin15.17%
Net Profit Margin12.04%
EBITDA Margin21.16%
EBIT Margin13.79%
Analyst Forecast
The average price target for Shandong Weigao Group Medical Polymer Co is HK$4.54, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$4.54
Price Target Upside30.32% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast7.47%
EPS Growth Forecast-26.89%